MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 214 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q2 2023. The put-call ratio across all filers is 0.87 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $339,164 | +32.5% | 1,400 | -50.1% | 0.01% | -68.8% |
Q4 2019 | $256,000 | -35.5% | 2,807 | -39.0% | 0.02% | -33.3% |
Q3 2019 | $397,000 | -80.3% | 4,600 | -76.0% | 0.02% | -89.1% |
Q2 2019 | $2,012,000 | +163.4% | 19,200 | +214.8% | 0.22% | +76.8% |
Q1 2019 | $764,000 | – | 6,100 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
EcoR1 Capital, LLC | 199,500 | $55,798,000 | 5.31% |
Avoro Capital Advisors LLC | 489,536 | $136,918,000 | 5.27% |
Rock Springs Capital Management LP | 342,300 | $95,738,000 | 3.68% |
Boxer Capital, LLC | 95,000 | $26,571,000 | 3.01% |
Baker Brothers Advisors | 1,169,278 | $327,035,000 | 2.46% |
Vivo Capital, LLC | 62,220 | $17,402,000 | 2.24% |
SHIKIAR ASSET MANAGEMENT INC | 17,541 | $4,906,000 | 2.05% |
Ghost Tree Capital, LLC | 23,500 | $6,573,000 | 1.93% |
HealthCor Management, L.P. | 197,281 | $55,178,000 | 1.75% |
ACUTA CAPITAL PARTNERS, LLC | 34,803 | $9,734,000 | 1.73% |